Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

The Vanishing Vaccine War
Motley Fool
Thursday, September 10, 2009 - 5:47pm
tags:
vaccines, Merck, GSK, HPV, Cervarix, Gardasil
FDA wants more data about Johnson & Johnson's ovarian cancer drug Yondelis
Yahoo/AP
Thursday, September 10, 2009 - 5:46pm
tags:
FDA, JNJ, Yondelis, ovarian cancer
Glaxo Moves Ahead With Cervarix
Yahoo/Zacks.com
Thursday, September 10, 2009 - 3:23pm
tags:
GSK, vaccines, Cervarix, HPV
Pfizer rated 'Overweight' on late stage pipeline
Yahoo/AP
Thursday, September 10, 2009 - 3:21pm
tags:
Pfizer, pipelines, Wyeth, bapineuzumab, Sutent, Prevnar 13
Goldman Sachs on Healthcare: ‘A Stock Picker’s Paradise’
WSJ Online
Thursday, September 10, 2009 - 3:20pm
tags:
drug stocks
Pharma shares flat a day after Obama speech reaffirms push for health care reform
Yahoo/AP
Thursday, September 10, 2009 - 3:19pm
tags:
drug stocks, Obama, healthcare reform
MS drug Tysabri reawakens brain virus -study
Forbes/Reuters
Thursday, September 10, 2009 - 11:31am
tags:
MS, Tysabri, Elan, Biogen Idec, PML, multiple sclerosis
Boehringer Ingelheim likely to have regulatory submission for Pradaxa delayed
FT.com
Thursday, September 10, 2009 - 11:26am
tags:
Boehringer Ingelheim, Pradaxa
Generic drugmaker stocks unaffected following Obama address on health care reform plans
Yahoo/AP
Thursday, September 10, 2009 - 11:24am
tags:
healthcare reform, generics, Mylan, Forest Labs
Merck ends development of an experimental migraine treatment, cites potential liver problems
Yahoo/AP
Thursday, September 10, 2009 - 11:02am
tags:
Merck, migraines
Top Facet Investor's Big Sell-Off
InVivo
Thursday, September 10, 2009 - 10:44am
tags:
Facet Biotech, M&A, Biogen Idec
Dynavax, Generex rocket as drug stocks dip
Marketwatch
Thursday, September 10, 2009 - 10:43am
tags:
Dynavax, Generex, drug stocks
Vical's swine flu vaccine works in mice, rabbits
Yahoo/AP
Thursday, September 10, 2009 - 10:38am
tags:
Vical, swine flu, vaccines, H1N1
Vivus's Qnexa Drug Approval Makes It a Nice Trade
Seeking Alpha
Thursday, September 10, 2009 - 10:36am
tags:
Vivus, obesity, Qnexa
Study weakens Lilly's fight against price controls
Indianapolis Business Journal, IN
Thursday, September 10, 2009 - 10:32am
tags:
price controls, Eli Lilly, healthcare reform
Judge To Give Jury 'Cooling Off' Period In Fosamax Case
NASDAQ.com
Thursday, September 10, 2009 - 10:30am
tags:
Fosamax, osteoporosis, lawsuits, Merck
Merck reports mixed data for migraine drug
Marketwatch
Thursday, September 10, 2009 - 8:59am
tags:
Merck, migraines
Report: Large Majorities of Public Blame Health Insurers, Drug Industry, Republicans, Business for Problems with Our Current Health Care
Fierce Biotech
Thursday, September 10, 2009 - 8:53am
tags:
drug industry, healthcare reform
Biogen Maintains Facet Offer
Yahoo/Zacks.com
Thursday, September 10, 2009 - 8:52am
tags:
Biogen Idec, Facet Biotech, M&A, Acorda Therapeutics, Bristol-Myers Squibb
FDA panel backs Gardasil for use by men
Yahoo/AP
Thursday, September 10, 2009 - 8:51am
tags:
FDA, Gardasil, Merck, vaccines, HPV

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.